Active substance against neutropenia (clinical research of the active substance Myelo001 in the indication chemotherapy induced neutropenia) (Q3313537)
Jump to navigation
Jump to search
Project Q3313537 in Germany
Language | Label | Description | Also known as |
---|---|---|---|
English | Active substance against neutropenia (clinical research of the active substance Myelo001 in the indication chemotherapy induced neutropenia) |
Project Q3313537 in Germany |
Statements
511,075.0 Euro
0 references
638,843.75 Euro
0 references
80.0 percent
0 references
6 January 2015
0 references
30 April 2018
0 references
ABX CRO advanced pharmaceu-tical services Forschungs-gesellschaft mbH
0 references
Wirkstoff gegen Neutropenie (Klinische Erforschung des Wirkstoffes Myelo001 in der Indikation Chemotherapie- induzierte Neutropenie) (German)
0 references
Active substance against neutropenia (clinical research of the active substance Myelo001 in the indication chemotherapy induced neutropenia) (English)
25 October 2021
0.0059835763390727
0 references
Principe actif contre la neutropénie (recherche clinique du principe actif Myelo001 dans l’indication de la neutropénie induite par la chimiothérapie) (French)
6 December 2021
0 references
Werkzame stof tegen neutropenie (klinische studie van de werkzame stof Myelo001 bij de indicatie chemotherapie geïnduceerde neutropenie) (Dutch)
19 December 2021
0 references
Principio attivo contro la neutropenia (ricerca clinica del principio attivo Myelo001 nell'indicazione neutropenia indotta da chemioterapia) (Italian)
19 January 2022
0 references
Principio activo contra neutropenia (investigación clínica del principio activo Myelo001 en la indicación de neutropenia inducida por quimioterapia) (Spanish)
22 January 2022
0 references
Δραστική ουσία κατά της ουδετεροπενίας (κλινική έρευνα της δραστικής ουσίας Myelo001 στην ένδειξη που προκαλείται από χημειοθεραπεία ουδετεροπενία) (Greek)
19 August 2022
0 references
Aktivt stof mod neutropeni (klinisk forskning af det aktive stof Myelo001 i indikationen kemoterapi induceret neutropeni) (Danish)
19 August 2022
0 references
Vaikuttava aine neutropeniaa vastaan (vaikuttavan aineen Myelo001 kliininen tutkimus solunsalpaajahoidon indusoiman neutropenian käyttöaiheessa) (Finnish)
19 August 2022
0 references
Sustanza attiva kontra n-newtropenja (riċerka klinika tas-sustanza attiva Myelo001 fl-indikazzjoni newtropenija kkaġunata mill-kimoterapija) (Maltese)
19 August 2022
0 references
Aktīvā viela pret neitropēniju (klīniskie pētījumi par aktīvo vielu Myelo001 ķīmijterapijas izraisītas neitropēnijas gadījumā) (Latvian)
19 August 2022
0 references
Liečivo proti neutropénii (klinický výskum liečiva Myelo001 v indikácii neutropénie vyvolanej chemoterapiou) (Slovak)
19 August 2022
0 references
Substaint ghníomhach i gcoinne neutropenia (taighde cliniciúil ar an tsubstaint ghníomhach Myelo001 sa cheimiteiripe léirithe a spreagtar neutropenia) (Irish)
19 August 2022
0 references
Léčivá látka proti neutropenii (klinický výzkum účinné látky Myelo001 v indikaci neutropenie indukované chemoterapií) (Czech)
19 August 2022
0 references
Substância ativa contra a neutropenia (investigação clínica da substância ativa Myelo001 na indicação neutropenia induzida por quimioterapia) (Portuguese)
19 August 2022
0 references
Toimeaine neutropeenia vastu (toimeaine Myelo001 kliinilised uuringud keemiaravi indutseeritud neutropeenia näidustusel) (Estonian)
19 August 2022
0 references
Hatóanyag neutropenia ellen (a Myelo001 hatóanyag klinikai vizsgálata kemoterápia indukálta neutropenia indikációban) (Hungarian)
19 August 2022
0 references
Активно вещество срещу неутропения (клинични изследвания на активното вещество Myelo001 при показанието химиотерапия, индуцирана неутропения) (Bulgarian)
19 August 2022
0 references
Veiklioji medžiaga prieš neutropeniją (klinikiniai veikliosios medžiagos Myelo001 tyrimai su chemoterapijos sukelta neutropenija) (Lithuanian)
19 August 2022
0 references
Djelatna tvar protiv neutropenije (klinička istraživanja djelatne tvari Myelo001 u indikaciji neutropenije izazvane kemoterapijom) (Croatian)
19 August 2022
0 references
Aktiv substans mot neutropeni (klinisk forskning om den aktiva substansen Myelo001 vid indikationen kemoterapi inducerad neutropeni) (Swedish)
19 August 2022
0 references
Substanță activă împotriva neutropeniei (cercetare clinică a substanței active Myelo001 în neutropenia indusă de chimioterapie cu indicație) (Romanian)
19 August 2022
0 references
Zdravilna učinkovina proti nevtropeniji (klinične raziskave zdravilne učinkovine Myelo001 za indikacijo nevtropenija, povzročena s kemoterapijo) (Slovenian)
19 August 2022
0 references
Substancja czynna przeciwko neutropenii (badania kliniczne substancji czynnej Myelo001 we wskazaniu dotyczącym neutropenii wywołanej chemioterapią) (Polish)
19 August 2022
0 references
Dresden, Stadt
0 references
Identifiers
672 / 101002072451
0 references